Cancer Research Annual Meeting 2010  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gauthier, M. L.
Right arrow Articles by Tlsty, T. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gauthier, M. L.
Right arrow Articles by Tlsty, T. D.
[Cancer Research 65, 1792-1799, March 1, 2005]
© 2005 American Association for Cancer Research


Cell and Tumor Biology

p38 Regulates Cyclooxygenase-2 in Human Mammary Epithelial Cells and Is Activated in Premalignant Tissue

Mona L. Gauthier1, Curtis R. Pickering1, Caroline J. Miller1, Colleen A. Fordyce1, Karen L. Chew2, Hal K. Berman1 and Thea D. Tlsty1

Departments of 1 Pathology and 2 Laboratory Medicine, University of California San Francisco Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California

Requests for reprints: Thea D. Tlsty, Department of Pathology, University of California San Francisco Comprehensive Cancer Center, University of California San Francisco, 513 Parnassus Avenue, HSW 451, San Francisco, CA, 94143-0511. Phone: 415-502-6116; Fax: 415-502-6163. E-mail: ttlsty{at}itsa.ucsf.edu.

The immediate-early gene, cyclooxygenase-2 (COX-2), is induced in a variety of inflammatory and neoplastic processes and is believed to play an important role in tumorigenesis. In this study, we identify an important upstream regulatory pathway of COX-2 expression in variant human mammary epithelial cells (vHMEC), which has been shown to exhibit phenotypes important for malignancy. We find that the stress-activated kinase, p38, is phosphorylated and activated in vHMEC compared with HMEC and is responsible for the expression of COX-2 in vHMEC as cells grow in culture. Furthermore in this capacity, p38 acts to stabilize the COX-2 transcript rather than activate COX-2 transcription. Inhibition of p38 kinase, using a chemical inhibitor, down-regulates COX-2 and decreases cell survival. Examination of archived tissue from women with ductal carcinoma in situ reveals epithelial cells that not only overexpress COX-2 but also have an abundance of activated phospho-p38 in the nucleus and cytoplasm, mirroring the expression observed in vitro. These epithelial cells are found within premalignant lesions as well as in fields of morphologically normal tissue that surround the lesions. In contrast, low phospho-p38 staining was observed in the majority of normal tissue obtained from reduction mammoplasty. These data help define the regulation of COX-2 expression in early carcinogenesis and provide alternative candidates for targeted prevention of COX-2-induced phenotypes and breast cancer.

Key Words: COX-2 • p38 • human mammary epithelial cells • ductal carcinoma in situ • field effect




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
M. A. Troester, M. H. Lee, M. Carter, C. Fan, D. W. Cowan, E. R. Perez, J. R. Pirone, C. M. Perou, D. J. Jerry, and S. S. Schneider
Activation of Host Wound Responses in Breast Cancer Microenvironment
Clin. Cancer Res., November 15, 2009; 15(22): 7020 - 7028.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. R. Neil, K. M. Johnson, R. A. Nemenoff, and W. P. Schiemann
Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-{beta} through a PGE2-dependent mechanisms
Carcinogenesis, November 1, 2008; 29(11): 2227 - 2235.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. R. Junttila, S.-P. Li, and J. Westermarck
Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival
FASEB J, April 1, 2008; 22(4): 954 - 965.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. Bradley, R. van der Meer, N. Roodi, H. Yan, M. B. Chandrasekharan, Z.-W. Sun, R. L. Mernaugh, and F. F. Parl
Carcinogen-induced histone alteration in normal human mammary epithelial cells
Carcinogenesis, October 1, 2007; 28(10): 2184 - 2192.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. S. Angelo and R. Kurzrock
Vascular Endothelial Growth Factor and Its Relationship to Inflammatory Mediators
Clin. Cancer Res., May 15, 2007; 13(10): 2825 - 2830.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. H. Ostrander, A. R. Daniel, K. Lofgren, C. G. Kleer, and C. A. Lange
Breast Tumor Kinase (Protein Tyrosine Kinase 6) Regulates Heregulin-Induced Activation of ERK5 and p38 MAP Kinases in Breast Cancer Cells
Cancer Res., May 1, 2007; 67(9): 4199 - 4209.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. A. Reynolds, M. Sigaroudinia, G. Zardo, M. B. Wilson, G. M. Benton, C. J. Miller, C. Hong, J. Fridlyand, J. F. Costello, and T. D. Tlsty
Tumor Suppressor p16INK4A Regulates Polycomb-mediated DNA Hypermethylation in Human Mammary Epithelial Cells
J. Biol. Chem., August 25, 2006; 281(34): 24790 - 24802.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
K J Schmitz, R Callies, J Wohlschlaeger, R Kimmig, F Otterbach, J Bohr, H-S Lee, A Takeda, K W Schmid, and H A Baba
Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with Her-2/neu signalling pathways
J. Clin. Pathol., July 1, 2006; 59(7): 685 - 691.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Ding, C. Erdmann, A. M. Chinnaiyan, S. D. Merajver, and C. G. Kleer
Identification of EZH2 as a Molecular Marker for a Precancerous State in Morphologically Normal Breast Tissues.
Cancer Res., April 15, 2006; 66(8): 4095 - 4099.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.